WO2004002968A1 - Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid - Google Patents

Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid Download PDF

Info

Publication number
WO2004002968A1
WO2004002968A1 PCT/EP2003/006360 EP0306360W WO2004002968A1 WO 2004002968 A1 WO2004002968 A1 WO 2004002968A1 EP 0306360 W EP0306360 W EP 0306360W WO 2004002968 A1 WO2004002968 A1 WO 2004002968A1
Authority
WO
WIPO (PCT)
Prior art keywords
dichloro
phenyl
formula
cyano
isothiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/006360
Other languages
German (de)
English (en)
French (fr)
Inventor
Thomas Himmler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience AG
Original Assignee
Bayer CropScience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience AG filed Critical Bayer CropScience AG
Priority to JP2004516609A priority Critical patent/JP4551762B2/ja
Priority to KR1020047021038A priority patent/KR101069222B1/ko
Priority to DE50301572T priority patent/DE50301572D1/de
Priority to EP03732578A priority patent/EP1519926B1/de
Priority to AT03732578T priority patent/ATE308530T1/de
Priority to AU2003238510A priority patent/AU2003238510A1/en
Publication of WO2004002968A1 publication Critical patent/WO2004002968A1/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to a new process for the preparation of the known 3,4-dichloro-N- (2-cyano-phenyl) -5-isothiazole carboxamide, which can be used as an active ingredient with microbicidal properties.
  • the method according to the invention is characterized by a number of advantages.
  • Suitable acid acceptors when carrying out the first stage of the process according to the invention are preferably tertiary amines.
  • tertiary amines examples include trimethylamine, triemylarnine, tributylamine, N, N-dimethylbenzylamine, pyridine, N-methylpiperidine, N-methylmorpholine, N, N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclonones (DBN) or diazabicycloundecene (DBU ).
  • Halogenated aromatic hydrocarbons such as toluene or chlorobenzene
  • chlorinated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane
  • amides such as dimethylformamide and dimethylacetamide. Dimethylformamide is particularly preferred.
  • Suitable dehydrating agents for carrying out the second stage of the process according to the invention are all those reagents which are suitable for eliminating water from A iden.
  • Mixtures of dimethylformamide and thionyl chloride, phosphorus oxychloride, phosgene or CMormethylene-dimethylammmonium chloride can preferably be used.
  • All customary aprotic, organic solvents can be used as diluents when carrying out the second stage of the process according to the invention.
  • Halogenated aromatic hydrocarbons such as toluene or chlorobenzene, can preferably be used, furthermore chlorinated hydrocarbons, such as dichloromethane, chloroform, carbon tetrachloride, dichloroethane or
  • Trichloroethane and also amides such as dimethylformamide and dimethylacetamide.
  • Dimethylformamide is particularly preferred.
  • the temperatures can be varied within a substantial range when carrying out the process according to the invention.
  • the first stage is carried out at temperatures between 0 ° C. and 160 ° C., preferably between 0 ° C. and 120 ° C.
  • work is generally carried out at temperatures between -20 ° C. and + 80 ° C., preferably between 0 ° C. and 60 ° C.
  • reaction in the first stage and the second stage is generally carried out under atmospheric pressure. However, it is also possible to work under increased pressure.
  • N- [2- (aminocarbonyl) phenyl] -3,4-dichloro-5-isothiazolecarboxamide of the formula (TV) are generally employed of dehydrating agent and optionally an excess of dimethylformamide.
  • the preparation Processing takes place according to customary methods, in general the procedure is followed by adding water to the reaction mixture and suctioning off, washing and drying the resulting solids.
  • the method according to the invention can be carried out as a one-pot reaction.
  • 3,4-dichloroisothiazole-5-carboxylic acid chloride of the formula (LT) is first reacted with anthranilic acid amide of the formula (HI) in the presence of acid acceptor and then added without prior isolation of the N- [2- (ammocarbonyl) phenyl] -3,4-dicMor-isothiazolcarboxamids of formula (TV) add the dehydration reagent.
  • the processing is again carried out according to the usual
  • a solution of 4.33 g (22 mmol) of 3,4-dichloroisothiazolecarboxylic acid chloride is added to a mixture of 15 ml of dimethylformamide, 3 g (22 mmol) of anthranilic acid amide and 2.23 g (22 mmol) of triethylamine at 60 ° C. while stirring dripped.
  • the reaction mixture is then stirred for a further hour at 60 ° C. and then concentrated under reduced pressure.
  • the remaining residue is stirred with 35 ml of water and then suction filtered.
  • the resulting, still moist solid is boiled with isopropanol, cooled to room temperature, suction filtered and dried.
  • Triethylamine in 24 g of dimethylformamide is added dropwise at room temperature with stirring, a solution of 8.66 g (40 mmol) of 3,4-dichloroisothiazole-5-carboxylic acid chloride in 20 g of dimethylformamide.
  • the reaction mixture is stirred at 20 ° C. for one hour.
  • 6.67 g (56 mmol) of thionyl chloride are added dropwise to the resulting suspension with stirring.
  • reaction mixture is stirred for a further 2 hours at room temperature, then 80 ml of water are added and the mixture is stirred for a further 15 minutes.
  • the resulting solid is filtered off, washed twice with 40 ml of water and dried.
  • the product obtained is boiled in 30 ml of isopropanol for 30 minutes. After cooling to room temperature, the resulting solid is suctioned off, twice with 10 ml each
  • Triethylamine in 12 g of dimethylformamide is added dropwise at room temperature with stirring, a solution of 4.33 g (20 mmol) of 3,4-dichloroisothiazole-5-carboxylic acid chloride in 10 g of dimethylformamide.
  • the reaction mixture is stirred at 20 ° C. for one hour.
  • 4.3 g (28 mmol) of phosphorus oxychloride are added dropwise to the resulting suspension at 0 ° C. while stirring.
  • the reaction mixture is stirred for a further 2 hours at 0 ° C., then mixed with 40 ml of water and stirred for a further 15 minutes.
  • a solution of 8.66 g (40 mmol) of 3,4-dichloroisothiazole-5 is added to a solution of 6 g (44 mmol) of anthranilic acid amide and 4.46 g (44 mmol) of triethylamine in 24 g of dimethylformamide at room temperature with stirring -carboxylic acid chloride added dropwise in 20 g of dimethylformamide.
  • the reaction mixture is stirred at 20 ° C. for one hour.
  • 5.6 g (56 mmol) of phosgene are introduced into the resulting suspension at 20-25 ° C. with stirring.
  • reaction mixture is stirred for a further 2 hours at room temperature, then 80 ml of water are added while cooling with ice and the mixture is stirred for a further 15 minutes.
  • the resulting solid is filtered off, washed twice with 40 ml of water and dried. The received
  • the aqueous phase is separated off from the two-phase filtrate and extracted twice with 150 ml of ethyl acetate each time.
  • the combined organic phases are dried over sodium sulfate and then concentrated under reduced pressure.
  • the remaining residue is stirred with 100 ml of petroleum ether and 25 ml of ethyl acetate.
  • the resulting solid is filtered off, washed with ethyl acetate and dried.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PCT/EP2003/006360 2002-06-27 2003-06-17 Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid Ceased WO2004002968A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2004516609A JP4551762B2 (ja) 2002-06-27 2003-06-17 3,4−ジクロロ−n−(2−シアノフェニル)−5−イソチアゾールカルボキサミドの製造方法
KR1020047021038A KR101069222B1 (ko) 2002-06-27 2003-06-17 3,4-디클로로-n-(2-시아노-페닐)-5-이소티아졸카복사미드의 제조방법
DE50301572T DE50301572D1 (de) 2002-06-27 2003-06-17 Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid
EP03732578A EP1519926B1 (de) 2002-06-27 2003-06-17 Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid
AT03732578T ATE308530T1 (de) 2002-06-27 2003-06-17 Verfahren zur herstellung von 3,4-dichlor-n-(2- cyano-phenyl)-5-isothiazolcarboxamid
AU2003238510A AU2003238510A1 (en) 2002-06-27 2003-06-17 Method for producing 3,4-dichloro-n-(2-cyano-phenyl)-5-isothiazole carboxamide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10228732.5 2002-06-27
DE10228732A DE10228732A1 (de) 2002-06-27 2002-06-27 Verfahren zur Herstellung von 3,4-Dichlor-N-(2-cyano-phenyl)-5-isothiazolcarboxamid

Publications (1)

Publication Number Publication Date
WO2004002968A1 true WO2004002968A1 (de) 2004-01-08

Family

ID=29723489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/006360 Ceased WO2004002968A1 (de) 2002-06-27 2003-06-17 Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid

Country Status (9)

Country Link
EP (1) EP1519926B1 (https=)
JP (1) JP4551762B2 (https=)
KR (1) KR101069222B1 (https=)
CN (1) CN1325483C (https=)
AT (1) ATE308530T1 (https=)
AU (1) AU2003238510A1 (https=)
DE (2) DE10228732A1 (https=)
TW (1) TWI266766B (https=)
WO (1) WO2004002968A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031146A1 (de) 2005-07-29 2007-03-22 Bayer Cropscience Aktiengesellschaft Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid
CN103483287A (zh) * 2013-10-12 2014-01-01 南开大学 一类含3,4-二氯异噻唑的双酰胺类化合物及其制备方法和用途
WO2018228984A1 (en) 2017-06-14 2018-12-20 Bayer Aktiengesellschaft Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
WO2019192988A1 (de) 2018-04-06 2019-10-10 Bayer Aktiengesellschaft Verfahren zur herstellung von 3,4-dichlor-n-(2-cyanophenyl)-5-isothiazolcarboxamid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024413A2 (de) * 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Isothiazolcarbonsäureamide und deren verwendung zum schutz von pflanzen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2115625B2 (de) * 1971-03-31 1978-07-06 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von N-o-Cyanophenyl-N', N'-disubstituierten Formamidinen und deren Salzen
DE2115624A1 (de) * 1971-03-31 1972-10-12 Badische Anilin & Soda Fabrik AG, 6700 Ludwigshafen Verfahren zur Herstellung von o Amino benzonitrilen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024413A2 (de) * 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Isothiazolcarbonsäureamide und deren verwendung zum schutz von pflanzen

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105254582A (zh) * 2005-07-29 2016-01-20 拜尔农作物科学股份公司 生产3,4-二氯-n-(2-氰基-苯基)-5-异噻唑羧酰胺的方法
JP2009502831A (ja) * 2005-07-29 2009-01-29 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 3,4−ジクロロ−n−(2−シアノフェニル)−5−イソチアゾールカルボキサミドを調製する方法
JP2013035846A (ja) * 2005-07-29 2013-02-21 Bayer Cropscience Ag 3,4−ジクロロ−n−(2−シアノフェニル)−5−イソチアゾールカルボキサミドを調製する方法
EP2573077A1 (de) 2005-07-29 2013-03-27 Bayer CropScience AG Verfahren zur Herstellung von 3,4-Dichlor-N-(2-cyano-phenyl)-5-isothiazolcarboxamid
CN103087003A (zh) * 2005-07-29 2013-05-08 拜尔农作物科学股份公司 生产3,4-二氯-n-(2-氰基-苯基)-5-异噻唑羧酰胺的方法
CN103102323A (zh) * 2005-07-29 2013-05-15 拜尔农作物科学股份公司 生产3,4-二氯-n-(2-氰基-苯基)-5-异噻唑羧酰胺的方法
KR101332310B1 (ko) 2005-07-29 2013-11-22 바이엘 크롭사이언스 아게 3,4-디클로로-n-(2-시아노페닐)-5-이소티아졸카복사미드의제조방법
CN105254582B (zh) * 2005-07-29 2017-12-26 拜耳知识产权有限责任公司 生产3,4‑二氯‑n‑(2‑氰基‑苯基)‑5‑异噻唑羧酰胺的方法
WO2007031146A1 (de) 2005-07-29 2007-03-22 Bayer Cropscience Aktiengesellschaft Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid
CN103483287B (zh) * 2013-10-12 2015-07-08 南开大学 一类含3,4-二氯异噻唑的双酰胺类化合物及其制备方法和用途
CN103483287A (zh) * 2013-10-12 2014-01-01 南开大学 一类含3,4-二氯异噻唑的双酰胺类化合物及其制备方法和用途
WO2018228984A1 (en) 2017-06-14 2018-12-20 Bayer Aktiengesellschaft Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
CN110719908A (zh) * 2017-06-14 2020-01-21 拜耳股份公司 用于制备3,4-二氯-n-(2-氰基苯基)-5-异噻唑甲酰胺的方法
US11220487B2 (en) 2017-06-14 2022-01-11 Bayer Aktiengesellschaft Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
IL271148B (en) * 2017-06-14 2022-08-01 Bayer Ag Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
TWI794243B (zh) * 2017-06-14 2023-03-01 德商拜耳廠股份有限公司 製備3,4-二氯-n-(2-氰苯基)-5-異噻唑羧醯胺之方法
CN110719908B (zh) * 2017-06-14 2023-05-26 拜耳股份公司 用于制备3,4-二氯-n-(2-氰基苯基)-5-异噻唑甲酰胺的方法
WO2019192988A1 (de) 2018-04-06 2019-10-10 Bayer Aktiengesellschaft Verfahren zur herstellung von 3,4-dichlor-n-(2-cyanophenyl)-5-isothiazolcarboxamid
US11339137B2 (en) 2018-04-06 2022-05-24 Bayer Aktiengesellschaft Method for producing 3,4-dichloro-N-(2-cyanophenyl)-5-isothiazolecarboxamide

Also Published As

Publication number Publication date
JP2005530847A (ja) 2005-10-13
CN1325483C (zh) 2007-07-11
DE50301572D1 (de) 2005-12-08
DE10228732A1 (de) 2004-01-15
AU2003238510A1 (en) 2004-01-19
TWI266766B (en) 2006-11-21
EP1519926A1 (de) 2005-04-06
EP1519926B1 (de) 2005-11-02
ATE308530T1 (de) 2005-11-15
CN1678595A (zh) 2005-10-05
JP4551762B2 (ja) 2010-09-29
KR101069222B1 (ko) 2011-09-30
TW200409762A (en) 2004-06-16
KR20050008853A (ko) 2005-01-21

Similar Documents

Publication Publication Date Title
EP2285779A1 (de) Verfahren zur herstellung von arylcarboxamiden
DE69322118T2 (de) Amino-Thiazolderivate und ihre Anwendung als Fungizide
DE19544800A1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE2655009C2 (https=)
DE1966974A1 (de) Dimethylformiminiumhalogensulfit- n-halogenide, verfahren zu deren herstellung sowie deren verwendung
DE60105441T2 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
EP1519926B1 (de) Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazolcarboxamid
EP0281841B1 (de) Verfahren zur Herstellung von 5-Amino-4,6-dihalogenpyridinen
EP1242405B1 (de) Verfahren zur herstellung von 4-(heteroaryl-methyl)-1(2h)-phthalazinonen
EP0187285B1 (de) Verfahren zur Herstellung von substituierten Phenylhydrazinen
EP0546420B1 (de) Verfahren zur Herstellung von substituierten Pyrazolinen
EP1519927B1 (de) Verfahren zur herstellung von 3,4-dichlor-n-(2-cyano-phenyl)-5-isothiazol-carboxamid
AT408756B (de) Verfahren zur herstellung von 2-chlor-5-chlormethyl-1,3-thiazol
EP1926717B1 (de) Verfahren zur Herstellung von 3,4-Dichlor-N-(2-cyano-phenyl)-5-isothiazolcarboxamid
EP0245646B1 (de) Verfahren zur Herstellung von 1-Aryl-5-amino-pyrazolen
EP3997076A1 (de) Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
EP1232151A1 (de) Verfahren zur herstellung von benzofuranonoximen
DE10017882A1 (de) Verfahren zur Herstellung von 4-Brom-und 4-Chlor-2-nitro-1-trifluormethoxy-benzol
DE2131788C3 (de) Verfahren zur Herstellung von 7-Pyrazolylcumarinen
DE10005278A1 (de) Verfahren zur Herstellung von Sulfonyl-imidazol-Derivaten
EP2167467A1 (de) Verfahren zur herstellung von dioxazin-derivaten
DE1595952A1 (de) Verfahren zur Herstellung von 5-Chlor-3-aminopyrazinoaten
WO2001047873A1 (de) Verfahren zur herstellung von n-substituierten 2,4-diamino-5-fluor-benzonitrilen und neue zwischenprodukte
EP0170057A2 (de) Verfahren zur Herstellung von N-Phenyl(Pyridyl)-sulfonyldiamiden
DD235258A5 (de) Verfahren zur herstellung von n-phenyl(pyridyl)-sulfonyldiamiden

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003732578

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 4107/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004516609

Country of ref document: JP

Ref document number: 1020047021038

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020047021038

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 20038203294

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2003732578

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2003732578

Country of ref document: EP